Fifth Third Bancorp’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-14,614
Closed -$2.59M 2319
2020
Q1
$2.59M Sell
14,614
-2,706
-16% -$510K 0.02% 352
2019
Q4
$3.31M Sell
17,320
-1,375
-7% -$248K 0.02% 362
2019
Q3
$3.15M Sell
18,695
-1,991
-10% -$324K 0.02% 349
2019
Q2
$3.46M Sell
20,686
-8,905
-30% -$1.23M 0.02% 333
2019
Q1
$4.33M Buy
29,591
+1,060
+4% +$154K 0.03% 298
2018
Q4
$3.81M Sell
28,531
-10,767
-27% -$1.77M 0.03% 294
2018
Q3
$7.49M Sell
39,298
-2,146
-5% -$394K 0.05% 252
2018
Q2
$6.91M Sell
41,444
-67,007
-62% -$10.8M 0.05% 255
2018
Q1
$18.3M Sell
108,451
-796
-0.7% -$134K 0.12% 164
2017
Q4
$17.9M Sell
109,247
-134,486
-55% -$24.1M 0.12% 156
2017
Q3
$50M Sell
243,733
-54
-0% -$12.6K 0.36% 82
2017
Q2
$59.3M Buy
243,787
+27,599
+13% +$6.49M 0.44% 68
2017
Q1
$51.7M Sell
216,188
-6,100
-3% -$1.42M 0.39% 74
2016
Q4
$46.7M Buy
222,288
+8,991
+4% +$1.86M 0.38% 79
2016
Q3
$49.1M Buy
213,297
+2,259
+1% +$552K 0.41% 70
2016
Q2
$48.8M Buy
211,038
+67,831
+47% +$15.6M 0.41% 65
2016
Q1
$38.4M Sell
143,207
-4,059
-3% -$1.16M 0.33% 90
2015
Q4
$46M Buy
147,266
+41,271
+39% +$12.3M 0.4% 69
2015
Q3
$28.8M Buy
105,995
+7,356
+7% +$2.26M 0.27% 105
2015
Q2
$29.9M Buy
98,639
+4,780
+5% +$1.43M 0.26% 110
2015
Q1
$27.9M Buy
93,859
+16,217
+21% +$4.62M 0.24% 112
2014
Q4
$20M Buy
77,642
+16,520
+27% +$4.13M 0.17% 137
2014
Q3
$14.7M Buy
61,122
+50,948
+501% +$11.4M 0.13% 152
2014
Q2
$2.27M Buy
10,174
+2,480
+32% +$513K 0.02% 427
2014
Q1
$1.58M Sell
7,694
-1
-0% -$198 0.01% 494
2013
Q4
$1.29M Buy
7,695
+3,553
+86% +$555K 0.01% 535
2013
Q3
$596K Buy
4,142
+745
+22% +$99.2K 0.01% 695
2013
Q2
$429K Buy
+3,397
New +$385K ﹤0.01% 748

Other funds holding AGN

Fifth Third Bancorp's AGN Position: Q2 2020 in Review

Fifth Third Bancorp sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 14,614 shares — an estimated $2.59M sold.

Fifth Third Bancorp first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $59.3M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Fifth Third Bancorp reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Fifth Third Bancorp sold 14,614 Allergan plc shares in Q2 2020, an estimated $2.59M.
  • Fifth Third Bancorp first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Fifth Third Bancorp's Allergan plc position peaked at $59.3M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Fifth Third Bancorp's 13F filing for Q2 2020, filed 5 Aug 2020.